All Posts by

Leslie Merryman

The History of the Term “Catatonia” in Cases of Encephalopathy

Congratulations to Drs. Visual Perera and Michael Okun on the publication of “The History of the Term “Catatonia” in Cases of Encephalopathy,” which appears in the April edition of Neurology. Abstract Objective: The neuropsychiatric term catatonia was born in the 19th century. We explored primary source documents to define the founder’s…

Real-world Outcomes Using DBS Systems with Directionality and Multiple Independent Current Control: USA Experience 

Congratulation to Drs. Michael Okun and Kelly Foote, on the publication of “Real-world Outcomes Using DBS Systems with Directionality and Multiple Independent Current Control: USA Experience,” which appears in the April edition of Neurology. Abstract Objective: Here, we present preliminary outcomes from an ongoing prospective, multicenter outcomes registry conducted at…

SUMO modifies GβL and mediates mTOR signaling

Congratulations to Dr. Srinavasa Subramaniam on the publication of “SUMO modifies GβL and mediates mTOR signaling,” which appears in the April edition of the Journal of Biological Chemistry. Introduction The mechanistic target of rapamycin (mTOR) signaling is influenced by multiple regulatory proteins and post-translational modifications; however, underlying mechanisms remain…

Diabetes drug shows promise against Parkinson’s in clinical study

Michael Okun, medical director of the Parkinson’s Foundation, told AFP that from a practical standpoint, the differences in patient outcomes were not clinically significant, but “statistically and compared to other studies, this type of difference should draw our interest and attention.” “Experts will likely argue whether this study meets a…

UF team plays major role in success of newly approved Duchenne muscular dystrophy drug

 Duchenne muscular dystrophy families, advocates and health care providers celebrated a milestone in March with the U.S. Food and Drug Administration’s approval of the first nonsteroidal drug for the treatment of Duchenne. In findings published in the April issue of The Lancet Neurology, a team of investigators led by pharmaceutical company Italfarmaco,…

Changes in Medicine

Congratulations to Dr. Kenneth Heilman on the publication of his new book “Changes in Medicine: The Way Forward,” which was published in February of 2024. The book presents the professional and personal history and milestones of renowned neurologist, Dr. Heilman, offers a unique perspective on neurology and medicine and discusses…

UNDERSTANDING PARKINSON’S DISEASE WITH DR. MICHAEL OKUN

Millions of people worldwide are living with Parkinson’s disease. Yet, despite its prevalence, there’s a lot of confusion and misunderstanding surrounding it. In this installment of Keeping the Well in Well-thy, Barbara Archer, and renowned neurologist Dr. Michael Okun, discuss the intricacies of Parkinson’s disease. They explore the wide range…

Hospitalization and Parkinson’s disease: safety, quality and outcomes

Congratulations to Dr. Michael Okun on the publication of “Hospitalization and Parkinson’s disease: safety, quality and outcomes,” which appears as an editorial in the April 4, 2024 edition of Frontiers . Introduction For people with Parkinson’s (PWP), hospital admissions can be perilous. Nearly 300,000 PWP are admitted to the hospital…